Published in Hepatitis Weekly, March 28th, 2005
This Pegasys combination therapy is effective in leading to a sustained virological response (SVR, indicative of a cure), providing a compelling reason to consider treatment in this previously undertreated patient group. Pegasys combination therapy is the only regimen approved in the U.S. for hepatitis C treatment in patients with HIV. Hepatitis C has become the most frequent cause of liver disease in HIV patients, and in some regions, may...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly